Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Effect Antioxidant and Serotonin Level in the Sera on Type II Diabetes Mellitus Males Patients and Compare with Control Group


Affiliations
1 Department of the Pathological Analysis Techniques, College of Al-Toosi University, Iran, Islamic Republic of
2 Department of Medicine, Najaf Iraq, Iraq
     

   Subscribe/Renew Journal


The study is intended to asses serum levels of Serotonin, malondialdehyde (MDA) and glutathione (GSH) in type 2 diabetic mellitus patients in comparison healthy groups of males, also correlation among Serotonin, MDA and GSH of DM patients. The study was conducted on selected 60 type 2 diabetic patients of males that attending to the diabetes mellitus center in Al-Sadder Teaching City in Al- Najaf province, Iraqi and a group of 60 apparently healthy subjects of males were included as a control group. The D M patients are divided into three groups of ages (15-19y), (20-39y) and (40-60 y). The Study was carried out from June 2018 to October 2018.The patients' age was ranging from 15 to 60 years old. The results also revealed that significant increase (p<0.05) in serum levels Serotonin and MDA in diabetic patients in comparing with healthy groups, while a significant decrease (p<0.05) in serum level GSH in diabetic patients in comparing with healthy groups. The results show that serum Serotonin level no significant (p>0.05) between (20-39y) and (40-60y) ages of D M patients, But there is a significant increase (p<0.05) in these ages groups than the ages (15-19y). The results show that serum MDA level increase significantly (p<0.05) with increasing age of patients and the ages (40-60y) are highly significant(p<0.05) than (20-39-54y) and (15-19y). The results show that serum GSH level no significant (p>0.05) between the ages (20-39y) and (40-60y) groups of D M patients, But there is a significant increase (p<0.05) in the ages (15-19y) than the ages (20-39y) and (40-60y) groups. The results have been shown a significant positive correlation (P<0.05) between serotonin and MDA in DM patients, and a significant negative correlation (P<0.05) between (serotonin and GSH), (MDA and GSH) in DM patients. Conclusion: The present study concluded that Serotonin, MDA and GSH were marker for detection and diagnosis of type 2 diabetic mellitus males patients.

Keywords

Type II Diabetes Mellitus, Oxidative Stress, Serotonin, MDA and GSH.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Canadian Diabetes Association (CDA). Clinical Practice Guideline for the Prevention and Management of Diabetes in Canada. Canad. J. Diabet. 2008; 32(1):1-201.

  • Peterson, K.F. and Shulman, G.I. Etiology of insulin resistance. Am. J. Med. 2006; 119: 10-16.

  • Alemzadeh, R.; Wyatt, D.T.; Behrman, R.E.; Kliegman, R.M. and Jenson, H.B. Diabetes mellitus in children. Nelson Textbook of Pediatrics.18th ed. Philadelphia: Saunders., 2008; 2404-31.

  • Baynest, H.W. Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. Baynes J. Diabetes. Metab. 2015; 6(5).

  • Su, Y.; Liu, X.M.; Sun, Y.M. and et al. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int. J. Clin. Pract., 2008; 62:877-82.

  • Newsholme, P.; Haber, E.P.; Hirabara, S.M. and et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and nonmitochondrial ROS production and activity. J. Physiol. 2007; 583:9-24.

  • Kahn, S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia, 2003; 46:3-19.

  • Kajimoto, Y. and Kaneto, H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann NY. Acad. Sci. 2004; 10(11):168-176.

  • Rahman, T.; Hosen, I.; Islam, T.; Shekhar, H.U. Oxidative stress and human health. Advances in Bioscience and Biotechnology. 2012; 3: 997-1019.

  • Sharma, P.; Jha, A.B.; Dubey, R.S. and Pessarakli, M. Reactive Oxygen Species, Oxidative Damage, and Anti oxidative Defense Mechanism in Plants under Stressful Conditions. Journal of Botany. 2012; 1-26.

  • Macias, H. and Romieu, I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J. Allergy Clin. Immunol. 2014; 133(5):1237-44.

  • Tangvarasittichai, S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J. Diabetes. 2015; 6(3): 456-480.

  • Wright, E.; J.R.; Scism-Bacon, J.L. and Glass, L.C.Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int. J. Clin. Pract. 2006; 60(3): 308–314.

  • Janeway, T.C.; Richardson, H.B. and Park, E.A. Experiments on the vasoconstrictor action of blood serum. Arch. Intern. Med. 1918; 21:565-603.

  • Zucker, M.B. A study of the substances in blood serum and platelets which stimulate smooth muscle. Am. J. Physiol. 1944; 142:12-26.

  • Rasbach, K.A.; Funk, J.A.; Jayavelu, T.; Green, P.T. and Schnellmann, R.G. 5-Hydroxytryptamine receptor stimulation of mitochondrial biogenesis. The Journal of Pharmacology and Experimental Therapeutics. 2010; vol. 332: 632–639.

  • Watanabe, S.; Matsumoto, T. Oda, M. and et al. Insulin augments serotonin-induced contraction via activation of the IR/PI3K/PDK1 pathway in the rat carotid artery. Pflügers Archiv-European Journal of Physiology. 2016; vol. 468, no. 4: 667–677.

  • Kim, K.; Oh, C-M.; Ohara-Imaizumi, M. and et al. Functional role of serotonin in insulin secretion in a diet-induced insulinresistant state. Endocrinology. 2015; vol. 156, : 444–452.

  • Oh, C-M.; Namkung, J.; Go, Y. and et al. Regulation of systemic energy homeostasis by serotonin in adipose tissues, ” Nature Communications. 2015; vol. 6: p. 6794.

  • Kwak, S.H.; Park, B.L.; Kim, H.; German, M.S.; Go, M.J. and et al. Association of variations in TPH1 and HTR2B with gestational weight gain and measures of obesity. Obesity (Silver Spring). 2012; 20:233-8.

  • Yang, Y.; Huang, H.; Xu, Z. and Jun-kai Duan. Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease. Journal of Diabetes Research. 2016; vol. 40:89–98.

  • Oh, C-M.; Park, S. and Kim. H. Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity, Obesity and Metabolic Syndrome, Diabetes Metab. J. 2016; 40:89-98.

  • Townsend, D.M.; Tew, K.D. and Tapiero, H. The importance of glutathione in human disease. Biomed Pharmacother. 2003; 57(34):145-55.

  • Wu, G.; Fang, Y.Z.; Yang, S.; Lupton, J.R. and Turner, N.D.(2004). Glutathione metabolism and its implications for health. J. Nutr. 134(3):489-92.

  • Kuhn, K.S., Krasselt, A.I. and Fuerst, P. Glutathione and glutathione metabolites in small tissue samples and mucosal biopsies. Clin Chem. 2003; 46:1003–1005.

  • Pastore, A.; Federici G, Bertini E, Piemonte F. Analysis of glutathione: Implication in redox and detoxification. Clin. Chim, Acta. 2003; 333:19-39.

  • Kalkan, I. H. and Suher, M. The relationship between the level of glutathione, impairment of glucose metabolism and complications of diabetes mellitus. Pak. J. Med. Sci. 2013; 29(4)938-942.

  • Cooper, A.J; Pinto, J.T. and Callery, P.S. Reversible and irreversible protein glutathionylation: biological and clinical aspects. Expert Opinion on Drug Metabolism and Toxicology. 2011; 7 (7): 891–910.

  • Foster, M.W.; Hess, D.T. and Stamler, J.S. (2009). Protein Snitrosylation in health and disease: a current perspective. Trends in Molecular Medicine. 2009; 15 (9): 391–404.

  • Lushchak, V. I. Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions. Journal of Amino Acids. 2012; 26: 26–43.

  • Schulz, T. B.; Lindenau, J.; Seyfried, J. and Dichgans, J. Eur. J. Biochem. 2000; 267: 4904.

  • Johnson, W. M., Delfosse, A. L. and Mieyal, J. J. Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases. Nutrients. 2012; 4: 1399-1440.

  • Saddala, R.; Thopireddy, L.; Ganapathi, N.; Kesireddy, S. R. Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with aqueous extract of Pimpinella tirupatiensis tuberous ischolar_main. Experimental and Toxicologic Pathology. 2013; 65(1-2):15–19.

  • Devi, G.S.; Prasad, M.H.; Saraswathi, I. and et al. Free radicals antioxidant enzymes and lipid peroxidation indifferent types of leukemias. Clinica. Chimica. Acta. 2000; 293: 53–62.

  • Pasupathi, P.; Chandraseker, V. and Kumar. U.S. Evaluation of oxidative stress, enzymatic and non enzymatic antioxidants and metabolic thyroid status in patients with diabetes mellitus. Diabetes & metabolic syndrome. Clinical Research & Reviews. 2009; 3: 160-165.

  • Depriviya, N.; Sudheer, A.R.; Vishwanathan, P. and Menon, V.P. Modulatory potential of ellagic acid, a natural plant on altered lipid profile and lipid peroxidation status during alcohol-induced toxicity: a pathohistological study. Journal of Biochemistry and Molecular Toxicology. 2008; 22(2): 101-12.

  • Singh, Z.; Karthigesu, I.P.; Singh, P.; Kaur, R. Use of Malondialdehyde as a Biomarker for Assessing Oxidative Stress in Different Disease Pathologies: a Review. · Iranian J. Publ. Health. 2014; 43, (3): 7-16

  • Del Rio, D.; Stewart, A.J. and Pellegrini, N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis.2005; 15:316-28.

  • Lupoae, M., Cristea, V., Coprean, D., Mocanu, M., Patriche, T. and Bocioc, E. Biochemical Determinations and Oxidative Stress Evaluation on oncorhynchusmykiss Grown in Recirculating System. Lucrări Stiin Ńifice. 2011; 55: 306–310.

  • Ramakrishna, V. and Jailkhani, R. Oxidative stress in non-insulindependent diabetes mellitus (NIDDM) patients. Acta. Diabetol. 2008; 45:41-6.

  • Soliman, GZ. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore, Med. J. 2008; 49:129-36.

  • Ezzeldin, E.; Souror, W.A.; El-Nahhas, T. Soudi, A.N. and Shahat, A.A. “Biochemical and neurotransmitters changes associated with tramadol in streptozotocin-induced diabetes in rats. BioMed Research International. 2014; 9 pages.

  • Hameed, A.; Ajmal, M.; Nasir, M. and Ismail, M. Genetic association analysis of serotonin transporter polymorphism (5-HTTLPR) with type 2 diabetes patients of Pakistani population. Diabetes Research and Clinical Practice. 2015; vol. 108: 67–71.

  • Gehlert, D.R. and Shaw, J. 5-Hydroxytryptamine 1A (5HT1A) receptors mediate increases in plasma glucose independent of corticosterone, ” European Journal of Pharmacology. 2014; vol. 745: 91–97.

  • Watanabe, S.; Matsumoto, T.; Oda, M. and et al. Insulin augments serotonin-induced contraction via activation of the R/PI3K/PDK1 pathway in the rat carotid artery. Pflügers Archiv-European Journal of Physiology. 2016; (468) (4): 667–677.

  • Gershon, M.D, and Ross, L.L. Location of sites of 5-hydroxytryptamine storage and metabolism by radioautography. J. Physiol.1966; 186:477-92.

  • Ekholm, R, Ericson, L.E.; Lundquist, I. Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography. Diabetologia. 1971; 7:339-48.

  • Ohta, Y.; Kosaka, Y.; Kishimoto, N.; Wang, J.; Smith, S.B.; Honig, G.; Kim, and et al. Convergence of the insulin and serotonin programs in the pancreatic beta-cell. Diabetes. 2011; 60:3208-16.

  • Ohara-Imaizumi, M.; Kim, H.; Yoshida, M.; Fujiwara, T.; Aoyagi, K.; Toyofuku, Y.; Nakamichi, Y. and et al. Serotonin regulates glucosestimulated insulin secretion from pancreatic beta cells during pregnancy. Proc. Natl. Acad. Sci. 2013; 110:19420-5.

  • Berger, M.; Scheel, D.W.; Macias, H.; Miyatsuka, T.; Kim, H.; Hoang, P.; Ku, G.M.; Honig, G. and et al. Galphai/o-coupled receptor signaling restricts pancreatic beta-cell expansion. Proc. Natl. Acad. Sci. 2015; 112: 2888-93.

  • Bianchi, P.; Pimentel, D.R.; Murphy, M.P.; Colucci, W.S. and Parini, A. A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB. J. 2005; 19: 641-643.

  • Foussal, C., Lairez, O., Calise., D, Pathak, A., Guilbeau-Frugier, C., Valet, P., Parini, A. and O. Kunduzova Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS. Lett. 2010; 584: 2363-2370.

  • Hara, K.; Hirowatari, Y.; Shimura, Y. and Takahashi, H. Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease. Diabetes. Res. Clin. Pract. 2011; 94:167-171.

  • Ali, T.; Shaheen, F.; Mahmud, M.; Waheed, H.; Jan, M.I.; Javed, Q. and Iram Murtaza, I. Serotonin-Promoted Elevation Of Ros Levels May Lead To Cardiac Pathologies In Diabetic Rat. Arch. Biol. Sci., Belgrade. 2015; 67(2):655-661.

  • D’Autreaux, B. and Toledano, M.B. ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell. Biol. 2007; 8:813-824.

  • Krause, K.H. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp. Gerontol. 2007; 42: 256-262.

  • Liu, F.; Li, N.; Long, B.; Fan, Y.Y.; Liu, C.Y.; Zhou, Q.Y.; Murtaza, I.; Wang, K. and Li, P.F. Cardiac hypertrophy is negatively regulated by miR-541. Cell Death and Disease. 2014; 5: P1171.

  • Brieger, K.; Schiavone, S.; Miller, F.J. Jr.; and K. H. Krause. Reactive oxygen species: from health to disease. Swiss. Med. Wkly. 2012; 142, w13659.

  • Kim, Y.G.; Moon, J.H.; Kim, K.; Kim, H.; Kim, J.; Jeong, J-S.; Lee, J.; Kang, S.; Park, J.S. and Kim, H. b-cell serotonin production is associated with female sex, old age, and diabetes-free condition. Biochemical and Biophysical Research Communications. 2017; 493: 1197-1203.

  • Simonenkov, A.P. and V. D. Fedorov, V.D. Are diabetic and agerelated angiopathies based on chronic serotonin insufficiency?.Bulletin of Experimental Biology and Medicine. 1997; 123(1):90-95.

  • Moranta, D.; Sarubbo, F.; Ramis, M. and et al. Positive effects of tryptophan and serotonin on cognition during aging and related-diseases. In book:chapter1; New Developments in Tryptophan Research. 2015.

  • Yilmaz, N.; Mermerdaş, Y.; Eren, E.; Yeğin, A.; Namiduru, E. Correlation between increased urinary serotonin levels and coronary artery disease in cigarette smoking patients. Turk. J. Med Sci. 2010; 40 (4): 531-536

  • Singh, S.R.; Hijam, D.; Dubey, A.; Devi, N.O.; Jamir, S.; Longkumer, C. and et al. Study Of Oxidative Stress Status In Type 2 Diabetic Patients.Int. J. Cont. Med. Res. 2015; 2(1):20-26

  • Jalees, S.S. and Rosaline, M. Study of malondialdehyde and estimation of blood glucose levels in patients with diabetes mellitus with cataract. International Journal of Clinical Biochemistry and Research. 2017; 4(3):319-323

  • Soni, N.O. Antioxidant assay in vivo and vitro’’. International Journal of Phytopharmacology. 2014; 5(1): 51-58.

  • Gupta, M.M. and Chari, S. Lipid Peroxidation and Antioxidant status in patients with Diabetic retinopathy. Indian J. Physiol. Pharmacol. 2005; 49 (2): 187–192.

  • Verma, M.K.; Singh, S.P.; Alam, R. and Verma, P. Comparative Study on MDA, SOD and HbA1c Levels in Patients of Type 2 Diabetes Mellitus with Retinopathy and without Retinopathy. Int. J. Pharm. Sci. Res. 2016; 7(10): 4184-90.

  • Shodehinde, S.A.; Oboh, G. Antioxidant properties of aqueous extracts of unripe Musa paradisiacal on sodium nitroprusside induced lipid peroxidation in rat pancreas in vitro. Asian Pacific Journal of Tropical Biomedicine. 2013; 3(6):449–457.

  • Fowler, M.J. Microvascular and macrovascular complications of diabetes. Clinical Diabetes. 2008; 26(2):77–82.

  • Pandey, K.B. AND Rizvi, S.I. Biomarkers of oxidative stress in red blood cells. Biomedical Papers. 2011; 155(2):131–136.

  • Yang, Z.; Laubach V. E., French B. A., Kron I. L. Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. Journal of Thoracic and Cardiovascular Surgery. 2009; 137(3):723–729.

  • Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes.1991; 40(4):405–412.

  • Ramesh, B.; Karuna, R.; Sreenivasa, R.S. and et al. Effect of Commiphora mukul gum resin on hepatic marker enzymes, lipid peroxidation and antioxidants status in pancreas and heart of streptozotocin induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 2012; 2(11):895–900.

  • Bandeira S.; Guedes, G.; da Fonseca, L.J.S.; Pires, A.S.; Gelain, D.P.; Moreira, J.C. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxidative Medicine and Cellular Longevity. 2012:13.

  • Tiwari, Pandey, K.B.; Abidi, A.B. and Syed Ibrahim Rizv, S.I. Markers of Oxidative Stress during Diabetes Mellitus. J. Biomark. 2013; 378790

  • Singh, K. and Singh, G. Alterations in some Oxidative Stress Markers in Diabetic Nephropathy. J. Cardiovasc. Disease Res. 2017; 8(1): 24-27.

  • Gawlik, K.; Naskalski, J.W.; Fedak, D.; Pawlica-Gosiewska, D.; Grudzien, U.; Dumnicka, P; MaBecki, M.T.; and Solnica, B. Oxidative Medicine and Cellular Longevity. 2016; 6 pages

  • Khan, S.; Naveed, A.K.; Shabbir, F.; Rajput, T.A. and Yousaf. M.J. Oxidative Stress in Patients with Type 2 Diabetes Mellitus. Journal of Rawalpindi Medical College (JRMC). 2014; 18(1):29-3

  • Rahigude, A.; Bhutada, P.; Kaulaskar, S.; Aswar, M. and Otari, K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience. 2012; 226:62–72.

  • Calabrese, V.; Cornelius, C.; Leso, V. and et al. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochimica et Biophysica Acta. 2012; 1822(5):729–736.

  • Dinçer, Y.; Akçay, T.; Alademir, Z. and Ilkova, H. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutation Research. 2002; 505(1-2):75–81.

  • Das, J.; Vasan, V. and Sil, P.C. Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicology and Applied Pharmacology. 2012; 258(2):296–308.

  • Livingstone, C. and Davis, J. Targeting therapeutics against glutathione depletion in diabetes and its complications. British Journal of Diabetes and Vascular Disease. 2007; 7(6):258–265.

  • Lutchmansingh, F.K.; Hsu, J.W.; Bennett. F.I.; Badaloo, A.V.; McFarlane-Anderson. N.; Gordon- Strachan, G.M and et al. Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS ONE. 2018; 13(6): e0198626.

  • Rizvi, S.I. and Maurya, P.K. Markers of oxidative stress in erythrocytes during aging in humans. Annals of the New York Academy of Sciences. 2007; 1100:373–382.

  • Schiffrin, E. L. Antioxidants in hypertension and cardiovascular disease. Molecular Interventions. 2010; 10(6):354–362.

  • Erdenİnal, M.; Kanbak, G.; Emine Sunal, E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clinica Chimica Acta. 2001; 305 (1–2): 75-80

  • Al-Koofee, D. Study Of Malondialdehyde, Reduced Glutathione, And Peroxy Nitrite Levels In Type 2 Diabetics Patients. Journal of Applicable Chemistry. 2013; 2 (6): 1581-1588

  • Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G. and et al. Oxidative stress, aging, and diseases. Clinical Interventions in Aging. 2018; 13:757–772.

  • El-Alfy, A. T., Ahmed, A. A. E. and Fatani, A. J. Protective effect of red grape seeds proanthocyanidins against induction of diabetes by alloxan in rats. Pharmacological Research. 2005; 52. 264–270.

  • Walaa G. Hozayen, Shaimaa S. Mahmoud, Kamal A. Amin and Rasha R. Ahmed Modulatory. Effects of Grape Seed Extract on Brain Neurotransmitters and Oxidative Stress in Alloxan Diabetic Rats..J Am. Sci. 2012; 8(12):243-254.

  • Priyatharshini, M.; Muraliswaran, P.; Kanagavalli, P. and G. Radhika, G. The Effect of Oxidative Stress And Inflammatory Status In PreDiabetic Subjects. IOSR Journal of Dental and Medical Science. 2017; 16 (12): 91-95.


Abstract Views: 218

PDF Views: 0




  • Effect Antioxidant and Serotonin Level in the Sera on Type II Diabetes Mellitus Males Patients and Compare with Control Group

Abstract Views: 218  |  PDF Views: 0

Authors

Ahmed Chyad Abbas
Department of the Pathological Analysis Techniques, College of Al-Toosi University, Iran, Islamic Republic of
Wijdan Rajh Hamza Al-Kraity
Department of the Pathological Analysis Techniques, College of Al-Toosi University, Iran, Islamic Republic of
Ebtihal Chiad Abbas
Department of Medicine, Najaf Iraq, Iraq

Abstract


The study is intended to asses serum levels of Serotonin, malondialdehyde (MDA) and glutathione (GSH) in type 2 diabetic mellitus patients in comparison healthy groups of males, also correlation among Serotonin, MDA and GSH of DM patients. The study was conducted on selected 60 type 2 diabetic patients of males that attending to the diabetes mellitus center in Al-Sadder Teaching City in Al- Najaf province, Iraqi and a group of 60 apparently healthy subjects of males were included as a control group. The D M patients are divided into three groups of ages (15-19y), (20-39y) and (40-60 y). The Study was carried out from June 2018 to October 2018.The patients' age was ranging from 15 to 60 years old. The results also revealed that significant increase (p<0.05) in serum levels Serotonin and MDA in diabetic patients in comparing with healthy groups, while a significant decrease (p<0.05) in serum level GSH in diabetic patients in comparing with healthy groups. The results show that serum Serotonin level no significant (p>0.05) between (20-39y) and (40-60y) ages of D M patients, But there is a significant increase (p<0.05) in these ages groups than the ages (15-19y). The results show that serum MDA level increase significantly (p<0.05) with increasing age of patients and the ages (40-60y) are highly significant(p<0.05) than (20-39-54y) and (15-19y). The results show that serum GSH level no significant (p>0.05) between the ages (20-39y) and (40-60y) groups of D M patients, But there is a significant increase (p<0.05) in the ages (15-19y) than the ages (20-39y) and (40-60y) groups. The results have been shown a significant positive correlation (P<0.05) between serotonin and MDA in DM patients, and a significant negative correlation (P<0.05) between (serotonin and GSH), (MDA and GSH) in DM patients. Conclusion: The present study concluded that Serotonin, MDA and GSH were marker for detection and diagnosis of type 2 diabetic mellitus males patients.

Keywords


Type II Diabetes Mellitus, Oxidative Stress, Serotonin, MDA and GSH.

References